{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT03043664","recordId":"NCT03043664","peptideSlug":"lanreotide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03043664-lanreotide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03043664.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct03043664.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2017-02-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2017-02-02","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"3f29a01cc6ba9a1c36f31729af10663e34d36360dc837cf154812e3aaac93a1c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2017-05-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"NOT_YET_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2017-05-23","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"f91f444ce8e1c21b5e340b092ee742c2e7a933ba1edabf297a4ff90a2f6b5967","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2017-07-31","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2017-07-31","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"d7eef93ab5337c9951e722015882728f0a4bb046a1af3fe1e95abd7939a0feaf","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2018-06-11","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2018-06-11","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"af512e8c164c5c0f4aaecf0b4df9cb97649cc9fe7e53325d0244090b25c06ebb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2019-06-26","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2019-06-26","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"1b70343b420d421d561a573cdff78deeb068d72c754b2a5b287d9e2e4a353236","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2019-07-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2019-07-03","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"e822106c30bdfbeee62cd2fea026eebb097f57afadc6fc10e0c6d12f57dd5c9b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2020-01-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"lanreotide","submittedDate":"2020-01-10","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"7aacb350957ee1c3bb3a31c3d83e63b4812925beaaadbf4d25c405d2ef5ce6be","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2020-02-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"SUSPENDED","peptideSlug":"lanreotide","submittedDate":"2020-02-12","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"3fae638bac4376af2e29ea77c7ea1408ce1d82e75943b1459046fe9da2f59787","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2020-04-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2020-04-03","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"d603e9ce8c5ac168d650303bc1619d743d2179ab58083283546f122f69ab3475","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2020-07-02","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2020-07-02","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"5627559671a21167de32995a4dacc3dc33855b4f6ae06cdd9ec202d426773e4d","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2020-11-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2020-11-10","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"6dd7868162675069af53128aee777fbbcd124ad7c18afcfa9b95975c7ec7dfa2","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2021-04-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2021-04-28","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"f0c9caf396ca17f58b5a49060357db206fd21641f3fe3884ffe66927bc28389f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2021-07-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2021-07-01","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"8641c8d11ef8e1f650a2c9e8bf46ccd01f6aaff4534e17ac4eb107c49a964ff3","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2021-10-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"lanreotide","submittedDate":"2021-10-01","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"850430e1f8dd082c12cb5e016b0d1a3d9622f25c61bc1a56b494abeada3d5118","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Outcome Measures","Outcome Measures (Results)","Study Status"],"historyVersion":17,"lastUpdateSubmitQcDate":"2022-09-01","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2022-09-01","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"d676697a98bfec74f7439a6db217714ae4c840ccfd55554b961a7d61922791cf","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=17&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures (Results)","Participant Flow","Study Status"],"historyVersion":18,"lastUpdateSubmitQcDate":"2023-06-12","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lanreotide","submittedDate":"2023-06-12","publishedAt":"2026-08-23","recordId":"NCT03043664","recordSha256":"6b663648cf73ded15d45ecf1239f13617d5a32a4fe18e10421f65441406e6f10","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT03043664?a=18&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"dc193b0b4890dda9a29fe00cfdb1012125168c4d0c8eac7be4210a071c70b7ad"}}